Publication | Closed Access

Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent

Insulin ResistanceMetabolic SyndromeDiabetes ManagementBiochemistryMedicineInsulin ManagementDiabetesNew Antidiabetic AgentPharmacological AgentInsulin DeliveryPharmacologyInsulin SignalingDrug DiscoveryHealth Sciences